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Background: Cough is one of the most common reasons for visiting a clinic. The causes of 
cough differ according to the duration of cough. Infectious disease is commonly observed in 
acute cough while noninfectious disease is commonly observed in chronic cough. On the other 
hand, cough is frequently observed in patients with asthma/cough variant asthma (CVA).
Objective: In this study, we investigated the causes of cough in a rural region in Japan and the 
clinical examination and treatment for the patients diagnosed as asthma/CVA.
Methods: We analyzed 124 patients who complained of cough.
Results: The most common reason for acute cough was respiratory tract infection while 
asthma/CVA is the most common reason for subacute and chronic cough. The diagnostic pro-
cedure for asthma/CVA depends on clinical symptoms in asthmatic patients with acute cough. 
While in asthmatic patients with subacute and chronic cough, diagnosis of asthma depends on 
clinical examinations including chest radiogram, immunoglobulin E, white blood cells counts, 
sputum examination or spirometry as well as symptoms. For the treatment of asthma, the use 
of long-acting β2-stimulant was dominant in asthmatic patients with acute cough while the use 
of leukotriene receptor and inhaled corticosteroid were dominant in asthmatic patients with 
subacute or chronic cough.
Conclusions: Diagnosis and treatment for asthma differs according to the duration of cough. 
Simple guidelines for asthma/CVA according to the duration of cough might be necessary for 
diagnosis and treatment of asthma/CVA for general physicians especially in rural areas.
Keywords: cough, diagnostic procedures, cough variant asthma, asthma
Introduction
Cough is the most frequent morbidity-related reason to visit a physician in the United 
States,1 Great Britain,2 Australia,3 and Japan.4 Several guidelines for diagnosis and 
management of cough have been established in the United States,5 Europe,6 and Japan.7 
The guidelines established in Japan categorize cough according to the duration of 
symptoms. Chronic cough is defined as persistent for more than eight weeks. Sub-
acute cough is defined as persistent for three to eight weeks. Acute cough is defined 
as persistent for less than three weeks.7
The likelihood of disease causing cough varies according to the duration of cough. 
In acute cough, causes of most cases are infectious diseases such as common cold or 
subsequent post-infectious cough. In subacute and chronic cough, the ratio of noninfec-
tious diseases is increased for causes of the cough in accordance with the duration of 
cough. Major causes of chronic cough are bronchial asthma, postnasal drip and gastro-
esophageal reflex disease (GERD) in the United States.5 On the other hand, Fujimura International Journal of General Medicine 2010:3 102
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and colleagues reported that main causes of chronic cough 
without any abnormal findings in chest X-ray test are atopic 
cough, sinobronchial syndrome and cough variant asthma 
(CVA) in Hokuriku area of Japan.8 Similar observations are 
obtained from other areas of Japan.9,10
The diagnostic procedures also affect cough etiology. The 
diagnosis of bronchial asthma is made based on symptoms 
such as cough, wheezing in the early morning or midnight, 
dyspnea, and chest oppression.11 A main symptom in patients 
with CVA is chronic cough.12 General examination includ-
ing chest X-ray test, complete blood counts with eosinophil 
number, spirometry, and sputum examination might be 
required for the differential diagnosis of chronic cough, CVA, 
or bronchial asthma. However, how physicians use these 
methods for diagnosis of asthma/CVA has not been studied 
yet. Furthermore, how physicians treat those patients who are 
diagnosed as asthma/CVA has not been well studied.
In 2003, the 2nd edition of Guideline for Diagnosis and 
Treatment of Cough was proposed by the Japanese Cough 
Research Society.7 In this guideline, differential diagnosis of 
chronic cough and diagnosis criteria for CVA, atopic cough, 
sinobronchial syndrome (SBS), postnasal drip, GERD, 
psychogenic cough and postinfectious cough are defined. 
However, it seems difficult for many general clinic physicians 
to diagnose patients with cough for bronchial asthma or CVA 
according to these criteria because of lack of equipment for 
cough provocation test, and spirometry.
In this study, we investigated the causes of acute, subacute 
and chronic cough in a rural region of Japan (San-in area) and 
the diagnostic procedure and treatment of patients who are 
diagnosed with CVA or bronchial asthma in this area.
Methods
This questionnaire-based study was conducted between April 
and June 2007 at 19 medical centers and nine clinics in the 
San-in area of Japan. During this period, 124 patients who 
visited a doctor for cough were questioned. Therefore, some 
but not all the patients visited the clinic for the first time for 
cough. This study was approved by the ethical committee 
of Tottori University. Informed consent was obtained from 
all subjects who participated in this study.
To conduct this study, we devised the questionnaire 
shown in Table 1 (originally described in Japanese). The 
spirometry, chest X-ray test, sputum eosinophilia, and com-
plete blood count including absolute eosinophil number, and 
C-reactive protein were measured by each physician. Final 
diagnoses of acute, subacute, or chronic cough were made 
by each physician (acute cough being defined as persistent 
cough for less than three weeks, and subacute cough being 
defined as cough for more than three weeks but less than 
eight weeks, and chronic cough being defined as cough for 
more than eight weeks).
statistical analysis
Kruskal–Wallis test analysis was used for comparison of age. 
Statistical analysis was performed with Graph-Pad Prism 4.0 
(Graph Pad Software Inc. San Diego, CA). Differences were 
considered to be statistically significant at P  0.05.
Results
characteristics of the patients
One hundred twenty-four patients visited the clinics complain-
ing of cough. Twenty-five patients suffered acute cough, 45 
had subacute cough, and 54 had chronic cough. The average 
age of the patients with acute cough was the lowest of the three 
groups, while the average age of the patients with chronic 
cough was the highest of the three groups. There was statistical 
difference between the patients with acute cough and chronic 
cough. The average age of the patients with subacute cough 
was the second youngest of the three groups and statistical 
difference was observed between the patients with subacute 
cough and chronic cough. The number of female patients was 
larger than that of male in the three groups (Table 2).
Figure 1 shows the age distribution of the patients. The 
number of patients with acute and subacute cough was larger 
under the age of 40 years. The number of patients with 
chronic cough was larger in most of the patients aged over 
50 years (Figure 1).
Table 3 shows the diagnosis of cough categorized by 
duration of cough. In the group of patients with acute cough, 
the percentage with asthma was 28.0%, while bronchitis 
Table 1 Questionnaire (originally described in Japanese)
1.  how long has it been since you have had cough?
   within one week    within two weeks 
   within three weeks    within one month 
   one to two months    more than two months
2.  Do you have symptoms such as wheezing or chest oppression?
   Yes   no
Table 2 characteristics of patients
  Total  Acute  Subacute  Chronic
number of patients  114  25  41  54
Average age (years)  50.5  44.4  45.2  57.4*
  standard deviation  17.4  19.7  14.1  16.4
  Range  18–74  18–78  20–82  20–84
Gender (female %)  67.5  76.0  63.4  64.8
*P  0.01, compared to acute or subacute groups.International Journal of General Medicine 2010:3 103
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caused by respiratory tract infection was 72.0%. In the group 
of patients with subacute cough, the percentage of asthma 
was 48.8%, the percentage of CVA is 9.7%, while the per-
centage of other diseases which are related to microorganism 
was 7.3%. Other causes were post infectious cough (12.2%), 
chronic obstructive pulmonary disease (COPD) (4.8%), SBS 
(2.4%), bronchiolitis associated with rheumatoid arthritis 
(2.4%), and causes of unknown origin (12.2%). In the group 
with chronic cough, the percentage of asthma was 44.4%; 
CVA was 9.3%. Other causes were postinfectious cough 
(11.1%), COPD (14.8%), SBS (7.4%), bronchiolitis associ-
ated with rheumatoid arthritis (3.7%), GERD (4.8%) and 
causes of unknown origin (9.3%).
In this study, the number of patients with CVA was 
small. Furthermore, since diagnostic process and treatment 
of asthma and CVA were similar, we analyzed the diagnosis 
procedure and treatment for patients with asthma and CVA. 
Table 4 shows the clinical tests and symptoms for the diag-
nosis of asthma and CVA. Among patients diagnosed as 
asthma/CVA in acute cough, chest X-ray test was performed 
in 57.1%, white blood cell counts with cell differentiation was 
measured in 42.8%, Immunoglobulin E (IgE) was measured 
in 14.3%, sputum eosinophilia was examined in 42.8%, 
and spirometry was performed in 57.1%. The percentage 
of patients who had typical symptoms of asthma such as 
wheezing or chest oppression was 85.7%. Among patients 
diagnosed as asthma/CVA in subacute cough, chest X-ray test 
was performed in 95.8%, white blood cell counts with cell 
differentiation was measured in 58.3%, IgE was measured 
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Figure 1 Distribution of age of patients with cough. The number of patients with acute and subacute cough is larger under the age of 40 years compared to the number 
of patients with chronic cough. The number of patients with chronic cough was larger compared to the number of patients with acute and subacute cough in most of the 
generation aged more than 50 years.
Table 3 causes of acute, subacute and chronic cough
  Acute  Subacute  Chronic
Asthma  28.0%  48.8%  44.5%
cVA  0%  9.7%  9.3%
Respiratory tract infection  72.0%  7.3%  0%
Post infectious cough  0%  12.2%  11.1%
cOPD  0%  4.8%  14.8%
sBs  0%  2.4%  7.4%
Bronchiolitis associated with RA  0%  2.4%  3.7%
GeRD  0%  0%  4.8%
Unknown  0%  12.2%  9.3%International Journal of General Medicine 2010:3 104
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in 25.0%, sputum eosinophilia was examined in 37.5%, 
and spirometry was performed in 70.8%. The percentage 
of patients who had typical symptoms of asthma such as 
wheezing or chest oppression was 54.2%. Among patients 
diagnosed as asthma/CVA in chronic cough, chest X-ray test 
was performed in 100.0%, white blood cell counts with cell 
differentiation was measured in 91.7%, IgE was measured 
in 72.4%, sputum eosinophilia was examined in 51.7%, and 
spirometry was performed in 79.3%. The percentage of the 
patients who had typical symptoms of asthma such as wheez-
ing or chest oppression was 82.8%.
We next analyzed treatment of asthma/CVA according 
to the duration of cough. Figure 2 shows the percentage of 
antiasthmatic drugs used with patients diagnosed as having 
asthma and CVA. Among patients with acute asthma/CVA, 
the percentage of inhaled corticosteroid (ICS) use was 
42.0%. But the percentage of ICS use increased according 
to the duration of cough (subacute, 70.0%; chronic, 100%). 
A similar trend was observed in leukotriene receptor antago-
nist (LTRA) use. The percentage of LTRA use increased 
according to the duration of cough. Among patients with 
acute cough, use was 30%, with subacute cough, use was 
40%, and with chronic cough, use was 60%, while the per-
centage of long-acting β2 agonist (LABA) use decreased 
according to the duration of cough. The percentage of LABA 
use was 58% in acute asthma/CVA, 42% in subacute and 
40% in chronic cough. The percentages of sustained-release 
theophylline use were highest in chronic asthma/CVA, sec-
ond highest in acute asthma/CVA and lowest in subacute 
asthma/CVA patients. Therefore, there was no correlation 
in use of sustained-release theophylline in patients with 
asthma/CVA and duration of asthma.
Table 4 clinical tests and symptoms performed for the diagnosis 
of asthma/cVA
  Acute  Subacute  Chronic
chest X-ray test  57.1%  95.8%  100.0%
White blood cell count  42.8%  58.3%  91.7%
Ige  14.3%  25.0%  72.4%
sputum eosinophil  42.8%  37.5%  51.7%
spirometry  57.1%  70.8%  79.3%
Typical symptoms of asthma   85.7%  54.2%  82.8% 
(wheezing, chest oppression) 
ICS
LTRA
LABA
Sustained-
release
theophylline
0 10 20 30 40 50 60 70 80 90 100
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Figure 2 The percentage of antiasthmatic drug used by patients with asthma/cVA according to the duration of cough. The percentage of Ics use increased according to the 
duration of cough (acute, 42%; subacute, 70%; chronic, 100%). The percentage of LTRA use also increased according to the duration of cough (acute, 30%; subacute, 40%; chronic, 
60%). The percentage of LABA use decreased according to the duration of cough (acute, 58%; subacute, 42%; chronic, 40%). The percentages of sustained-release theophylline 
use did not correlate with the duration of asthma (acute, 40%; subacute, 20%; chronic, 29%).
Abbreviations: cVA, cough variant asthma; Ics, inhaled corticosteroids; LABA, long-acting β2-agonists; LTRA, leukotriene receptor antagonist.International Journal of General Medicine 2010:3 105
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Discussion
Cough is the most frequent symptom for patients to visit 
clinic or hospital worldwide including Japan.1,3,4 Many dis-
eases cause cough, but the distribution of diseases causing 
cough differs according to the duration of cough. The causes 
of acute or subacute cough tend to be infectious disease13 
while the causes of chronic cough are likely noninfectious 
diseases.8,14 Like previous studies, this study showed that 
the percentage of infectious diseases was high for causes of 
acute cough while the percentage of noninfectious diseases 
increased as the duration of cough became longer.
Causes of chronic cough differ among areas in Japan. 
Atopic cough and CVA are the most common causes of 
chronic cough.8,10 In this study, we found that bronchial 
asthma is the most common cause of chronic cough as well 
as of subacute cough. The second most common cause for 
chronic cough is CVA, the third is COPD, and the fourth is 
postinfectious cough. These differences between our results 
and others might come from the study period. In this study, 
we studied for a period of three months from April 1st to 
June 30th, 2007 while Fujimura and colleagues8 studied for 
about seven months and Shirahata and colleagues10 studied 
for over 12 months. Other reasons for these differences could 
be clinical background since those two studies might have 
excluded typical asthma and chronic obstructive pulmonary 
disease from patients complaining of chronic cough because 
they surveyed patients with no remarkable findings in chest 
X-ray test and normal spirometry. There are subtle differ-
ences among areas of Japan in etiology of chronic cough. 
Fujimura and colleagues8 reported that CVA/asthma is the 
most common cause of chronic cough. Atopic cough is the 
second and sinobronchial syndrome is the third most com-
mon cause. Shirahata and colleagues10 and Fujimori and col-
leagues9 also reported that CVA is the most common causes 
of chronic cough. However, Shirahata and colleagues10 have 
reported that the second most common cause is nonspecific 
and the third most common cause is sinobronchial syndrome. 
Fujimori and colleagues reported that the second most com-
mon cause of the subacute is postinfectious and third most 
common is atopic cough. The reasons for these differences 
are not clear. However, confusion, or lack of consensus in 
disease entities which cause subacute and chronic cough 
might be one possible reason. Geographic issues such as 
distribution of general practitioners, local hospital general-
ists and respiratory physicians also affect the diagnosis of 
subacute and chronic cough. Therefore, causes of subacute 
and chronic cough in rural areas of Japan would be somewhat 
different from those in other studies.
Furthermore, diagnostic procedures or criteria might 
relate to the subtle differences in diagnosis of chronic 
cough. Fujimura and colleagues made differential diagnosis 
according to criteria recommended by the Japanese Cough 
Research Society.15 In their study, causes of cough were 
diagnosed symptoms, blood examinations, chest and sinus 
X-ray tests, examination of sputum eosinophilia, spirometry, 
capsaicin-induced cough sensitivity, bronchial responsive-
ness to methacholine and effectiveness of treatment for 
each disease. However, the precise diagnosis of CVA or 
atopic cough according to the Japanese Respiratory Society 
Guidelines7 for general physicians is very difficult. In our 
study, spirometry was performed on more than half of the 
patients with CVA/asthma and the percentage of patients 
who had spirogram increased as to the duration of cough 
increased, though the percentage did not reach 100%. On the 
other hand, blood examination is easy to carry out in general 
clinics and hospitals. The percentage of the patients who 
had the blood examination carried out including IgE and 
eosinophils increased according to the duration of cough. 
However, the percentage of patients with IgE checked was 
smaller than those who were measured blood eosinophils. 
This result may indicate that the physicians measured blood 
white blood cells with differentiation to diagnose or exclude 
respiratory infectious disease. However, peripheral blood 
eosinophil as well as basophil percentage are important and 
useful for diagnosis of bronchial asthma.16 Furthermore, 
serum IgE is elevated in atopic and nonatopic asthma.17 The 
percentage of patients who checked sputum eosinophilia was 
about 50% of the patients who were diagnosed with asthma. 
The reason for this low percentage might be related to the 
patients’ symptoms because this study was carried out for 
patients who had cough as a main symptom.
In this study, chest X-ray test was performed in almost all 
the patients with asthma among chronic cough and subacute 
cough groups. The diagnostic procedure to exclude diseases 
such as lung cancer, tuberculosis and interstitial pneumonia, 
is important because misdiagnosis and mistreatment of these 
diseases is critical.18–20 In this study, general physicians as 
well as pulmonary specialists must be careful to exclude 
these diseases. Furthermore, consequences of the exclusion of 
these diseases by chest X-ray test might lead to diagnosis of 
asthma/CVA. Induced sputum with hypertonic saline might 
be considered on patients with dry cough to show airway 
inflammation for diagnosis of asthma/CVA.
In this study, the treatment for asthma/CVA was ana-
lyzed. The percentage of ICS use in the patients with acute 
asthma/CVA was below 50%, but this percentage increased International Journal of General Medicine 2010:3 106
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according to the duration of cough and reached 100% in 
chronic asthma. Similar results were obtained in use of 
LTRA. In contrast to the use of ICS, the percentage of LABA 
use was over 50% but decreased according to the duration of 
cough. Since inhaled bronchodilator is used for the diagno-
sis and treatment of CVA,21 our results indicate that LABA 
might be used for acute asthma/CVA patients for treatment 
as well as for the diagnosis. On the other hand, the ICS might 
be used for the definite treatment for persistent symptoms 
such as subacute and chronic cough. ICS is most effective 
treatment for asthma and should be used in mild persistent, 
moderate and severe asthmatic patients22 or step 2 or more.23 
Furthermore, Fujimura and colleagues have reported that 
nearly 30% of CVA patients develop typical asthma and no 
ICS use is one of the risks in developing typical asthma.24 
Therefore, the treatment of chronic asthma/CVA in this rural 
area is compatible with international guidelines.
A number of limitations must be noted in this study. 
Firstly, the diagnosis of asthma or CVA has been made by 
each physician with laboratory findings as well as clinical 
symptoms. Therefore, diagnosis of asthma/CVA depends 
on each physician. Secondly, we asked the treatment for 
asthma/CVA according to each physician’s diagnosis. 
This also includes diagnostic therapy. Since the Japanese 
guideline for diagnosis and management of cough7 recom-
mends using bronchodilator therapy for CVA for the initial 
diagnosis, it may influence the prevalence of LABA or 
sustained-release theophylline use. Finally, other disease 
such as COPD, GERD, or SBS is also diagnosed by each 
physician. However, our diagnostic procedures might be 
more practical in rural areas where sophisticated equipment 
is not readily available.
In the present study, it was difficult for the general physi-
cians to use spirometry, sputum examination, measurement of 
capsaicin-induced cough sensitivity, and bronchial responsive-
ness to methacholine for diagnosis of asthma/CVA. However, 
most of the physicians were good at excluding the patients 
who were not asthma by checking X-ray test in almost all the 
patients who were diagnosed as asthma/CVA. Montnemery 
and colleagues have reported that general physicians are good 
at excluding patients who do not have asthma but not good at 
diagnosing patients who actually have asthma in Sweden.25 The 
precise diagnosis of asthma/CVA patients who complains of 
cough might be difficult. But clinical symptoms and laboratory 
tests such as peripheral blood examination, pulmonary func-
tion test, sputum examination and chest X-ray test are useful 
for asthma/CVA diagnosis. Simple diagnostic guidelines for 
asthma/CVA might be needed for general physicians.
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